Anne Whitaker, who has been working as the CEO of Synta, will be leaving the company and heading to a "large multinational pharmaceutical company." Synta Pharmaceuticals has named its third new CEO since March 2014, having tapped a former Teva Pharmaceuticals executive who joined in December as chief operating officer to take the place of Anne Whitaker , who is said to be heading to a "large multinational pharmaceutical company."